BridgeMD
dTap booster vaccination of health care workers (HC dTap)
EU CTIS ID: 2024-511478-56-00
What this study is testing
To study pertussis, diphtheria, and tetanus immunity in health care workers before their booster vaccination with dTap vaccine and the immunological response 4 weeks after the booster vaccination.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Working constantly with infants <12 months of age and thus requirement for dTap booster vaccination every 5 years
- > 4 years from the previous dTap vaccination
- Compliant with study procedures (2 visits with questionnaires, blood and MLF samples, planning to receive the dTap vaccine)
You likely can't join if
- Medical exempt not being able to be vaccinated (e.g. severe allergic reaction from some of the components in the vaccine)
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.